Zhejiang Medicine Co Ltd (600216) — Long-term Investment Intensity
Zhejiang Medicine Co Ltd (600216) has a Long-term Investment Intensity of 2.5% as of September 2019. Long-term investments of CN¥269.10 Million represent 2.5% of total assets of CN¥10.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Zhejiang Medicine Co Ltd (600216) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zhejiang Medicine Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Zhejiang Medicine Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 2.5%, reflecting long-term investments of CN¥269.10 Million against total assets of CN¥10.59 Billion CNY. Also explore Zhejiang Medicine Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Zhejiang Medicine Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Zhejiang Medicine Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600216 market cap.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.6% | CN¥258.21 Million | CN¥10.05 Billion | ▼ -0.1 pp |
| 2017 | 2.6% | CN¥257.55 Million | CN¥9.79 Billion | ▼ -0.7 pp |
| 2016 | 3.3% | CN¥292.67 Million | CN¥8.81 Billion | ▼ -0.8 pp |
| 2015 | 4.1% | CN¥341.54 Million | CN¥8.25 Billion | — |